Ana Lazaro-Carrillo

Ana Lazaro-Carrillo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2015 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
SKSusanne Kossatz
Susanne Kossatz
JGJulia Grandke
Julia Grandke
PCPierre Couleaud
Pierre Couleaud
ALAlfonso Latorre
Alfonso Latorre
AAAntonio Aires
Antonio Aires
IHIngrid Hilger
Ingrid Hilger
Introduction: Tumor cells can effectively be killed by heat, e.g. by using magnetic hyperthermia. The main challenge in the field, however, is the generation of therapeutic temperatures selectively in the whole tumor region. We aimed to improve magnetic hyperthermia of breast cancer by using innovative nanoparticles which display a high heating potential and are functionalized with a cell internalization and a chemotherapeutic agent to increase cell death. Methods: The superparamagnetic iron oxide nanoparticles (MF66) were electrostatically functionalized with either Nucant multivalent pseudopeptide (N6L; MF66-N6L), doxorubicin (DOX; MF66-DOX) or both (MF66-N6LDOX). Their cytotoxic potential was assessed in a breast adenocarcinoma cell line MDA-MB-231. Therapeutic efficacy was analyzed on subcutaneous MDA-MB-231 tumor bearing female athymic nude mice. Results: All nanoparticle variants showed an excellent heating potential around 500 W/g Fe in the alternating magnetic field (AMF, conditions: H = 15.4 kA/m, f = 435 kHz). We could show a gradual inter- and intracellular release of the ligands, and nanoparticle uptake in cells was increased by the N6L functionalization. MF66-DOX and MF66-N6LDOX in combination with hyperthermia were more cytotoxic to breast cancer cells than the respective free ligands. We observed a substantial tumor growth inhibition (to 40% of the initial tumor volume, complete tumor regression in many cases) after intratumoral injection of the nanoparticles in vivo. The proliferative activity of the remaining tumor tissue was distinctly reduced. Conclusion: The therapeutic effects of breast cancer magnetic hyperthermia could be strongly enhanced by the combination of MF66 functionalized with N6L and DOX and magnetic hyperthermia. Our approach combines two ways of tumor cell killing (magnetic hyperthermia and chemotherapy) and represents a straightforward strategy for translation into the clinical practice when injecting nanoparticles intratumorally.

26 February 2015 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
MCMacarena Calero
Macarena Calero
MCMichele Chiappi
Michele Chiappi
ALAna Lazaro-Carrillo
Ana Lazaro-Carrillo
MRMaría José Rodríguez
María José Rodríguez
FCFrancisco Javier Chichón
Francisco Javier Chichón
JCJosé L Carrascosa
José L Carrascosa
Different superparamagnetic iron oxide nanoparticles have been tested for their potential use in cancer treatment, as they enter into cells with high effectiveness, do not induce cytotoxicity, and are retained for relatively long periods of time inside the cells. We have analyzed the interaction, internalization and biocompatibility of dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles with an average diameter of 15 nm and negative surface charge in MCF-7 breast cancer cells. Cells were incubated with dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles for different time intervals, ranging from 0.5 to 72 h. These nanoparticles showed efficient internalization and relatively slow clearance. Time-dependent uptake studies demonstrated the maximum accumulation of dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles after 24 h of incubation, and afterwards they were slowly removed from cells. Superparamagnetic iron oxide nanoparticles were internalized by energy dependent endocytosis and localized in endosomes. Transmission electron microscopy studies showed macropinocytosis uptake and clathrin-mediated internalization depending on the nanoparticles aggregate size. MCF-7 cells accumulated these nanoparticles without any significant effect on cell morphology, cytoskeleton organization, cell cycle distribution, reactive oxygen species generation and cell viability, showing a similar behavior to untreated control cells. All these findings indicate that dimercaptosuccinic acid-coated superparamagnetic iron oxide nanoparticles have excellent properties in terms of efficiency and biocompatibility for application to target breast cancer cells.

1 May 2014 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
MCMacarena Calero
Macarena Calero
LGLucía Gutiérrez
Lucía Gutiérrez
GSGorka Salas
Gorka Salas
YLYurena Luengo
Yurena Luengo
ALAna Lazaro-Carrillo
Ana Lazaro-Carrillo
ÁVÁngeles Villanueva
Ángeles Villanueva

6 December 2016 in Scientific Reports
Verified
Journal Article
Open access
Konstantinos SimeonidisKonstantinos Simeonidis
Konstantinos Simeonidis
MMM. Puerto Morales
M. Puerto Morales
Marzia MarcielloMarzia Marciello
Marzia Marciello
MAMAKIS ANGELAKERIS
MAKIS ANGELAKERIS
Patricia De La PresaPatricia De La Presa
Patricia De La Presa
DSDavid Serantes
David Serantes
Promising advances in nanomedicine such as magnetic hyperthermia rely on a precise control of the nanoparticle performance in the cellular environment. This constitutes a huge research challenge due to difficulties for achieving a remote control within the human body. Here we report on the significant double role of the shape of ellipsoidal magnetic nanoparticles (nanorods) subjected to an external AC magnetic field: first, the heat release is increased due to the additional shape anisotropy; second, the rods dynamically reorientate in the orthogonal direction to the AC field direction. Importantly, the heating performance and the directional orientation occur in synergy and can be easily controlled by changing the AC field treatment duration, thus opening the pathway to combined hyperthermic/mechanical nanoactuators for biomedicine. Preliminary studies demonstrate the high accumulation of nanorods into HeLa cells whereas viability analysis supports their low toxicity and the absence of apoptotic or necrotic cell death after 24 or 48 h of incubation.

20 December 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
Asier EcharriAsier Echarri
Asier Echarri
DPDácil M. Pavón
Dácil M. Pavón
SSSara Sánchez
Sara Sánchez
MGMaría García-García
María García-García
ECEnrique Calvo
Enrique Calvo
MPMiguel A. del Pozo
Miguel A. del Pozo
Cells remodel their structure in response to mechanical strain. However, how mechanical forces are translated into biochemical signals that coordinate the structural changes observed at the plasma membrane (PM) and the underlying cytoskeleton during mechanoadaptation is unclear. Here, we show that PM mechanoadaptation is controlled by a tension-sensing pathway composed of c-Abl tyrosine kinase and membrane curvature regulator FBP17. FBP17 is recruited to caveolae to induce the formation of caveolar rosettes. FBP17 deficient cells have reduced rosette density, lack PM tension buffering capacity under osmotic shock, and cannot adapt to mechanical strain. Mechanistically, tension is transduced to the FBP17 F-BAR domain by direct phosphorylation mediated by c-Abl, a mechanosensitive molecule. This modification inhibits FBP17 membrane bending activity and releases FBP17-controlled inhibition of mDia1-dependent stress fibers, favoring membrane adaptation to increased tension. This mechanoprotective mechanism adapts the cell to changes in mechanical tension by coupling PM and actin cytoskeleton remodeling.

1 February 2020 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
ALAna Lazaro-Carrillo
Ana Lazaro-Carrillo
MFMarco Filice
Marco Filice
MGMaría José Guillén
María José Guillén
RARebeca Amaro
Rebeca Amaro
MVMario Viñambres
Mario Viñambres
Marzia MarcielloMarzia Marciello
Marzia Marciello